Phase 1 Equity Announces it’s First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio

CHICAGO, IL / ACCESS Newswire / January 7, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Ohio to its growing network.

This practice treats each patient as a family member and delivers flexibility in offering highly personalized care backed by state-of-the-art technology. This community-based practice thrives on delivering exceptional care while maintaining a culture built on trust, innovation, and a relentless focus on a friendly and relaxed patient experience. This marks Phase 1 Equity’s first practice added in 2026, it’s 19th doctor to join the platform and brings total locations to 26.

“We are thrilled to welcome another leading orthodontic practice in the State of Ohio to the platform” said Mike Rice, CEO of Phase 1 Equity. “We continue to bring both short and long-term value to our doctors as our platform continues to grow. Our unique model supports our doctor-led practices with the tools and resources they need while they maintain complete control over their practice.”

“We are very excited to welcome this great practice to Phase 1 Equity,” said Dr. Keith Kohrs, DDS, founding partner and board member. “They’ve been a great family oriented based practice with a strong reputation for delivering the best care and creating an outstanding patient experience. We’re excited to share knowledge, collaborate, and support their continued growth and success.”

About Phase 1 Equity

Phase 1 Equity is a doctor-owned platform created specifically for orthodontists and pediatric dentists. Our distinctive Doctor Equity™ model successfully combines private practice with private equity, allowing doctors to retain complete control over clinical and practice decision-making, while benefiting from the collective power of a nationwide network of like-minded practitioners. Doctors have access to decades of expertise and resources that optimize practice operations, reduce costs, enhance profitability, and maximize practice value. Unlike a sale to a traditional DSO, Phase 1 Equity’s partnership approach works with doctors to build substantial practice value and increase EBITDA before a sale to private equity. This ensures doctors receive a significantly larger share of the financial rewards in a future sale, compared to a traditional DSO model.

We’re not a traditional DSO. We’re a community of doctors building something meaningful-together.

Headquartered in Chicago, Illinois. Visit www.Phase1Equity.com or contact info@phase1equity.com to learn more

SOURCE: Phase 1 Equity

View the original press release on ACCESS Newswire

Staff

Recent Posts

Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies

HOUSTON, Jan. 8, 2026 /PRNewswire/ -- Bionova Scientific LLC, an Asahi Kasei company and a…

55 minutes ago

Doceree Emerges as Healthcare Marketing’s Most AI-Forward Technology Platform, Building Industry’s First Operating System for the AI Era

Company unifies its AI ecosystem under doceree.ai, launches five industry-first AI solutions, earns top global…

55 minutes ago

Longevity “GOAT” Dr. Mark Hyman Joins Jane Fonda as Keynote Speaker for the 2026 Livelong Women’s Health Summit

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Livelong Media is proud to announce Dr. Mark…

55 minutes ago

Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets

CHATTANOOGA, Tenn., Jan. 8, 2026 /PRNewswire/ -- Cleanova, a leading global manufacturer of advanced industrial filtration…

55 minutes ago

Zifo at JPM Healthcare Conference 2026: Why Technology Alone Cannot Deliver the AI Promise

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- The life sciences industry is buzzing about AI's…

55 minutes ago

Cumulus Neuroscience Appoints Ricardo Sáinz Fuertes, MD as New Board Chair

BELFAST, Northern Ireland, Jan. 8, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global…

56 minutes ago